Baran, N., Lodi, A., Patel, S., Ortiz, J. E., Collins, M., Sharma, P., Mohanty, V., Dede, M., Veletic, I., Ramage, C. L., Park, J. H., Dhungana, Y., Skwarska, A., Zhou, Y., Zeng, Z., Weng, C., Hayes, K., Alatrash, G., Dunner, K., Marszalek, J. R., Borthakur, G., Yu, J., Thandapani, P., Davis, R., Kaipparettu, B. A., Chen, K., Bhattacharya, P. K., Tiziani, S., Konopleva, M. (2025). CRISPR-Cas9 screen-driven identification of metabolic vulnerabilities reveals synthetic lethality via synergistic targeting of mitochondrial energy pathways and lactate export in oxphos-dependent T-ALL. Blood. https://doi.org/10.1182/blood-2025-1538